This is a Validated Antibody Database (VAD) review about human PODXL, based on 91 published articles (read how Labome selects the articles), using PODXL antibody in all methods. It is aimed to help Labome visitors find the most suited PODXL antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
PODXL synonym: Gp200; PC; PCLP; PCLP-1

Invitrogen
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; rhesus macaque; 1:100; fig 2c
Invitrogen PODXL antibody (eBioscience, 14-8863) was used in immunocytochemistry on rhesus macaque samples at 1:100 (fig 2c). Sci Rep (2021) ncbi
mouse monoclonal (TRA-1-81)
  • immunocytochemistry; rhesus macaque; 1:100; fig 2a
Invitrogen PODXL antibody (eBioscience, 14-8883) was used in immunocytochemistry on rhesus macaque samples at 1:100 (fig 2a). Sci Rep (2021) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; 1:1000; loading ...
Invitrogen PODXL antibody (Thermo, MA1-023) was used in flow cytometry on human samples at 1:1000. Cells (2021) ncbi
mouse monoclonal (cl.A)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1e
Invitrogen PODXL antibody (Thermo Fisher, 41-1000) was used in immunohistochemistry - paraffin section on human samples (fig 1e). Stem Cell Reports (2020) ncbi
mouse monoclonal (cl.26)
  • immunocytochemistry; human; 1:300; loading ...; fig 4a
Invitrogen PODXL antibody (ThermoFisher, 41-1100) was used in immunocytochemistry on human samples at 1:300 (fig 4a). elife (2019) ncbi
mouse monoclonal (cl.A)
  • immunocytochemistry; human; 1:300; loading ...; fig 4a
Invitrogen PODXL antibody (ThermoFisher, 41-1000) was used in immunocytochemistry on human samples at 1:300 (fig 4a). elife (2019) ncbi
mouse monoclonal (TRA-1-81)
  • immunohistochemistry; human; 1:100; fig 1c
Invitrogen PODXL antibody (ThermoFisher, MA1-024) was used in immunohistochemistry on human samples at 1:100 (fig 1c). Nat Commun (2018) ncbi
mouse monoclonal (TRA-1-60)
  • immunohistochemistry; human; 1:50; fig 1c
Invitrogen PODXL antibody (ThermoFisher, MA1-023) was used in immunohistochemistry on human samples at 1:50 (fig 1c). Nat Commun (2018) ncbi
mouse monoclonal (3D3)
  • immunocytochemistry; dogs; 1:100; loading ...; fig 1c
In order to investigate that role of zonula occludens-2 in Rho protein activation and epithelial development, Invitrogen PODXL antibody (Invitrogen, 39-3800) was used in immunocytochemistry on dogs samples at 1:100 (fig 1c). Biochim Biophys Acta Mol Cell Res (2017) ncbi
mouse monoclonal (cl.A)
  • immunocytochemistry; human; fig s2i
In order to probe the role of mTOR-dependent signaling among neuronal and nonneuronal cells in myelin regulation, Invitrogen PODXL antibody (Invitrogen, 411000) was used in immunocytochemistry on human samples (fig s2i). J Exp Med (2017) ncbi
mouse monoclonal (3D3)
  • immunocytochemistry; human; 1:50; loading ...; fig 1a
In order to ask if podocyturia increases in Fabry patients and correlates with clinical severity of Fabry nephropathy, Invitrogen PODXL antibody (Invitrogen, 39-3800) was used in immunocytochemistry on human samples at 1:50 (fig 1a). PLoS ONE (2016) ncbi
mouse monoclonal (cl.A)
  • immunocytochemistry; human; 1:200; loading ...; tbl 1
In order to investigate somatic reprogramming of adult cells to induced pluripotent stem cells, Invitrogen PODXL antibody (Thermo Fisher, 41-1000) was used in immunocytochemistry on human samples at 1:200 (tbl 1). J Vis Exp (2016) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; mouse; 1:500; loading ...; fig s1c
In order to study metabotropic glutamate receptor 5 in a murine model of fragile X syndrome, Invitrogen PODXL antibody (Thermo Fisher, MA1-023) was used in immunocytochemistry on mouse samples at 1:500 (fig s1c). Dev Neurobiol (2017) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; 1:50; fig 1
Invitrogen PODXL antibody (eBioscience, 14-8863-82) was used in immunocytochemistry on human samples at 1:50 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (cl.26)
  • immunocytochemistry; human; fig 1
In order to elucidate the mechanism responsible for a rare case of a female with mucopolysaccharidosis type II via X-chromosome inactivation analysis in different cell types and induced pluripotent stem cells, Invitrogen PODXL antibody (Invitrogen, 41-1100) was used in immunocytochemistry on human samples (fig 1). Folia Biol (Praha) (2016) ncbi
mouse monoclonal (cl.A)
  • immunocytochemistry; human; 1:100; fig 1
In order to research human iPS-derived motor neurons from sporadic ALS patients for gene expression and a strong association between neurodegeneration and mitochondrial functions, Invitrogen PODXL antibody (Life Technologies, 411000) was used in immunocytochemistry on human samples at 1:100 (fig 1). Front Cell Neurosci (2015) ncbi
mouse monoclonal (cl.26)
  • immunocytochemistry; human; 1:100; fig 1
In order to research human iPS-derived motor neurons from sporadic ALS patients for gene expression and a strong association between neurodegeneration and mitochondrial functions, Invitrogen PODXL antibody (Life Technologies, 411100) was used in immunocytochemistry on human samples at 1:100 (fig 1). Front Cell Neurosci (2015) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; 1:500
In order to study the effects of donor age and passage number on the efficiency of iPSC induction, Invitrogen PODXL antibody (Thermo Fisher, MA1-023) was used in immunocytochemistry on human samples at 1:500. Stem Cell Res (2015) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; 1:500; fig 1
In order to establish a human iPSC line, Invitrogen PODXL antibody (Thermo Fisher, MA1-023) was used in immunocytochemistry on human samples at 1:500 (fig 1). Stem Cell Res (2015) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; 1:500; fig 1a
In order to describe the creation of a human iPSC line HEL24.3, Invitrogen PODXL antibody (Thermo Fisher, MA1-023) was used in immunocytochemistry on human samples at 1:500 (fig 1a). Stem Cell Res (2015) ncbi
mouse monoclonal (cl.A)
  • immunocytochemistry; human; 1:100; fig 1
In order to study induced pluripotent stem cells derived from patients with amyotrophic lateral sclerosis, Invitrogen PODXL antibody (Life Technologies, 41-1000) was used in immunocytochemistry on human samples at 1:100 (fig 1). Dis Model Mech (2015) ncbi
mouse monoclonal (3D3)
  • immunocytochemistry; human; 1:500; fig 1
In order to assess the role of podocalyxin in osteosarcoma, Invitrogen PODXL antibody (Invitrogen, 39-3800) was used in immunocytochemistry on human samples at 1:500 (fig 1). Mol Med Rep (2015) ncbi
mouse monoclonal (3D3)
  • western blot; human
In order to study the molecular basis for cisplatin chemoresistance in oral tongue squamous cell carcinoma, Invitrogen PODXL antibody (Life Technologies, 39-3800) was used in western blot on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (TRA-1-81)
  • immunocytochemistry; common marmoset; 1:50; fig 2
Invitrogen PODXL antibody (eBioscience, 14-8883) was used in immunocytochemistry on common marmoset samples at 1:50 (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; common marmoset; 1:50; fig 2
Invitrogen PODXL antibody (eBioscience, 14-8863) was used in immunocytochemistry on common marmoset samples at 1:50 (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (3D3)
  • western blot; human; fig 1
In order to investigate the effect of crosstalk between PODX and Ang-(1-7)/Mas signaling in glioblastoma multiforme cells, Invitrogen PODXL antibody (Life Technologies, 39-3800) was used in western blot on human samples (fig 1). Oncol Rep (2015) ncbi
mouse monoclonal (cl.26)
  • western blot; human; 1:100
In order to describe a method to generate cystic fibrosis transmembrane conductance regulator protein-expressing airway epithelial cells from human pluripotent stem cells, Invitrogen PODXL antibody (Zymed, 41-1100) was used in western blot on human samples at 1:100. Nat Protoc (2015) ncbi
mouse monoclonal (cl.A)
  • western blot; human; 1:100
In order to describe a method to generate cystic fibrosis transmembrane conductance regulator protein-expressing airway epithelial cells from human pluripotent stem cells, Invitrogen PODXL antibody (Zymed, 41-1000) was used in western blot on human samples at 1:100. Nat Protoc (2015) ncbi
mouse monoclonal (cl.26)
  • immunocytochemistry; human
In order to report a protocol using a non-integrating Sendai virus vector for transduction of Yamanaka factors into urine cells collected from patients with muscular dystrophy, Invitrogen PODXL antibody (Life Technologies, 411100) was used in immunocytochemistry on human samples . J Vis Exp (2015) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human
Invitrogen PODXL antibody (eBioscience, 14-8863-82) was used in immunocytochemistry on human samples . Methods Mol Biol (2016) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human
In order to describe a method to rapidly generate neurons from human-induced pluripotent stem cells to elucidate the underlying regulatory programs, Invitrogen PODXL antibody (eBioscience, TRA-1/6) was used in flow cytometry on human samples . Mol Syst Biol (2014) ncbi
mouse monoclonal (3D3)
  • western blot; human; 1:1000
In order to explored the impact of crosstalk between PODX and beta-cat signaling in glioblastoma multiform cells, Invitrogen PODXL antibody (Life Technologies, 39-3800) was used in western blot on human samples at 1:1000. PLoS ONE (2014) ncbi
mouse monoclonal (3D3)
  • western blot; human; 1:10000
In order to study the relationship between SPAG9 and PODXL in human astrocytoma invasion, Invitrogen PODXL antibody (Invitrogen Life Technologies, 39-3800) was used in western blot on human samples at 1:10000. Mol Med Rep (2014) ncbi
mouse monoclonal (TRA-1-81)
  • flow cytometry; human; 1:100
Invitrogen PODXL antibody (eBioscience, 14-8883) was used in flow cytometry on human samples at 1:100. Stem Cell Rev (2014) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; 1:100
Invitrogen PODXL antibody (eBioscience, 14-8863) was used in flow cytometry on human samples at 1:100. Stem Cell Rev (2014) ncbi
mouse monoclonal (3D3)
  • immunohistochemistry; human; 1:500; fig 1
  • western blot; human; fig 3
In order to investigate the molecular mechanism that result in PINK1-mediated dissipation of the mitochondrial membrane potential, Invitrogen PODXL antibody (Life Technologies, 39-3800) was used in immunohistochemistry on human samples at 1:500 (fig 1) and in western blot on human samples (fig 3). J Biol Chem (2013) ncbi
mouse monoclonal (3D3)
  • western blot; human; 1:10000; fig 1
In order to test the effect of PODXL on astrocytoma cell invasion and survival against a chemotherapy agent, Invitrogen PODXL antibody (Life Technologies, 39-3800) was used in western blot on human samples at 1:10000 (fig 1). Exp Ther Med (2013) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; 1:250
Invitrogen PODXL antibody (eBioscience, 13-8863-82) was used in immunocytochemistry on human samples at 1:250. Nature (2012) ncbi
mouse monoclonal (cl.A)
  • immunocytochemistry; human; fig 8
In order to use TaqMan Protein Assays to quantify the kinetics and cellular levels of transcription factors during the reprogramming process of induced pluripotent stem cells, Invitrogen PODXL antibody (Life Technologies, 41-1000) was used in immunocytochemistry on human samples (fig 8). Stem Cells Dev (2012) ncbi
mouse monoclonal (cl.26)
  • immunocytochemistry; human; fig 8
In order to use TaqMan Protein Assays to quantify the kinetics and cellular levels of transcription factors during the reprogramming process of induced pluripotent stem cells, Invitrogen PODXL antibody (Life Technologies, 41-1100) was used in immunocytochemistry on human samples (fig 8). Stem Cells Dev (2012) ncbi
mouse monoclonal (3D3)
  • western blot; human; fig 7
In order to determine if PINCH1 translocates to the nucleus and regulates gene expression, Invitrogen PODXL antibody (Invitrogen, 39-3800) was used in western blot on human samples (fig 7). PLoS ONE (2011) ncbi
mouse monoclonal (cl.26)
  • flow cytometry; human
In order to report the first selection system for the isolation of human induced pluripotent stem cells, Invitrogen PODXL antibody (Invitrogen, 41-1100) was used in flow cytometry on human samples . Nat Methods (2009) ncbi
mouse monoclonal (cl.A)
  • flow cytometry; human
  • immunocytochemistry; human
In order to report the first selection system for the isolation of human induced pluripotent stem cells, Invitrogen PODXL antibody (Invitrogen, 41-1000) was used in flow cytometry on human samples and in immunocytochemistry on human samples . Nat Methods (2009) ncbi
Santa Cruz Biotechnology
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; loading ...; fig 1h
Santa Cruz Biotechnology PODXL antibody (Santa, sc-21705) was used in immunocytochemistry on human samples (fig 1h). J Comp Neurol (2019) ncbi
mouse monoclonal (TRA-1-80)
  • immunocytochemistry; human; loading ...; fig 1i
Santa Cruz Biotechnology PODXL antibody (Santa, sc-21706) was used in immunocytochemistry on human samples (fig 1i). J Comp Neurol (2019) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; 1:50; loading ...; fig 1f
Santa Cruz Biotechnology PODXL antibody (SantaCruz, sc21705) was used in immunocytochemistry on human samples at 1:50 (fig 1f). Stem Cell Res (2018) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; 1:100; fig 1g
Santa Cruz Biotechnology PODXL antibody (Santa Cruz, sc-21705) was used in flow cytometry on human samples at 1:100 (fig 1g). Stem Cell Res (2018) ncbi
mouse monoclonal
  • western blot; human; loading ...; fig s4d
Santa Cruz Biotechnology PODXL antibody (Santa Cruz, Sc-393716) was used in western blot on human samples (fig s4d). J Clin Invest (2017) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; domestic rabbit; 1:100; loading ...; fig 2
In order to study the mechanisms by which stem cells are capable of unlimited self-renewal and remain undifferentiated for extended periods of time prior to differentiation into specific cell lineages, Santa Cruz Biotechnology PODXL antibody (Santa Cruz, sc-21705) was used in flow cytometry on domestic rabbit samples at 1:100 (fig 2). Stem Cell Res Ther (2017) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; fig 2a
Santa Cruz Biotechnology PODXL antibody (Santa Cruz, sc-21705) was used in immunocytochemistry on human samples (fig 2a). Biol Open (2017) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; 1:200; fig 1
Santa Cruz Biotechnology PODXL antibody (SCBT, SC21705) was used in immunocytochemistry on human samples at 1:200 (fig 1). Stem Cell Res (2016) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; loading ...; fig S4C
Santa Cruz Biotechnology PODXL antibody (Santa Cruz, sc-21705) was used in flow cytometry on human samples (fig S4C). Genes Dev (2016) ncbi
mouse monoclonal (TRA-1-60)
  • western blot; human; fig 4
Santa Cruz Biotechnology PODXL antibody (Santa Cruz, TRA-1-60) was used in western blot on human samples (fig 4). Glycoconj J (2017) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; 1:100; fig 1
Santa Cruz Biotechnology PODXL antibody (Santa Cruz, sc-21705) was used in flow cytometry on human samples at 1:100 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (TRA-1-80)
  • immunocytochemistry; human; 1:200; fig s1
In order to study the recapitulation of the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity due to human induced pluripotent stem cell-derived cardiomyocytes, Santa Cruz Biotechnology PODXL antibody (Santa Cruz, sc-21706) was used in immunocytochemistry on human samples at 1:200 (fig s1). Nat Med (2016) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; 1:200; fig s1
In order to study the recapitulation of the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity due to human induced pluripotent stem cell-derived cardiomyocytes, Santa Cruz Biotechnology PODXL antibody (Santa Cruz, sc-21705) was used in immunocytochemistry on human samples at 1:200 (fig s1). Nat Med (2016) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; 1:250; fig 2
Santa Cruz Biotechnology PODXL antibody (santa Cruz, SC21705) was used in immunocytochemistry on human samples at 1:250 (fig 2). Virol J (2016) ncbi
mouse monoclonal (3D3)
  • blocking or activating experiments; human; loading ...
  • flow cytometry; human; loading ...; fig 3a
  • immunohistochemistry; human; loading ...; fig 3b
  • western blot; human; loading ...; fig 1d
In order to evaluate the 3D3 PODXL antibody for the elimination of tumorigenic pluripotent cells, Santa Cruz Biotechnology PODXL antibody (Santa Cruz, sc-23904) was used in blocking or activating experiments on human samples , in flow cytometry on human samples (fig 3a), in immunohistochemistry on human samples (fig 3b) and in western blot on human samples (fig 1d). Stem Cells Dev (2016) ncbi
mouse monoclonal (TRA-1-80)
  • immunocytochemistry; human; 1:400; loading ...; tbl 1
In order to optimize conditions to generate human pluripotent stem cell-derived limbal epithelial stem cells, Santa Cruz Biotechnology PODXL antibody (Santa Cruz, sc-21706) was used in immunocytochemistry on human samples at 1:400 (tbl 1). Exp Eye Res (2016) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; 1:50; fig 1
Santa Cruz Biotechnology PODXL antibody (Santa Cruz, sc-21705) was used in immunocytochemistry on human samples at 1:50 (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (TRA-1-80)
  • immunocytochemistry; human; tbl 2
Santa Cruz Biotechnology PODXL antibody (Santa Cruz, sc-21706) was used in immunocytochemistry on human samples (tbl 2). Exp Cell Res (2015) ncbi
mouse monoclonal (TRA-1-80)
  • immunocytochemistry; African green monkey; 1:100; fig 1s2
Santa Cruz Biotechnology PODXL antibody (Santa Cruz, SC-21706) was used in immunocytochemistry on African green monkey samples at 1:100 (fig 1s2). elife (2015) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; 2 ug/ml; fig 1a
  • immunocytochemistry; human; 2 ug/ml
Santa Cruz Biotechnology PODXL antibody (Santa Cruz Biotechnology, TRA-1-60) was used in flow cytometry on human samples at 2 ug/ml (fig 1a) and in immunocytochemistry on human samples at 2 ug/ml. J Biol Chem (2015) ncbi
mouse monoclonal (TRA-1-80)
  • immunocytochemistry; rhesus macaque; 1:50; fig s10
  • immunocytochemistry; human; 1:50; fig s8
Santa Cruz Biotechnology PODXL antibody (Santa Cruz, SC-21706) was used in immunocytochemistry on rhesus macaque samples at 1:50 (fig s10) and in immunocytochemistry on human samples at 1:50 (fig s8). Nature (2015) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; 1:50; fig s8
  • immunocytochemistry; rhesus macaque; 1:50; fig s10
Santa Cruz Biotechnology PODXL antibody (Santa Cruz, SC-21705) was used in immunocytochemistry on human samples at 1:50 (fig s8) and in immunocytochemistry on rhesus macaque samples at 1:50 (fig s10). Nature (2015) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; 1:50
Santa Cruz Biotechnology PODXL antibody (Santa Cruz, sc-21705) was used in immunocytochemistry on human samples at 1:50. Methods Mol Biol (2016) ncbi
mouse monoclonal (3D3)
  • immunocytochemistry; human; 1:200
In order to evaluate a co-culture system for studying the neurovascular unit, Santa Cruz Biotechnology PODXL antibody (Santa Cruz, sc-23904) was used in immunocytochemistry on human samples at 1:200. PLoS ONE (2014) ncbi
mouse monoclonal (TRA-1-80)
  • immunocytochemistry; human
Santa Cruz Biotechnology PODXL antibody (Santa Cruz, sc-21706) was used in immunocytochemistry on human samples . Biomaterials (2014) ncbi
mouse monoclonal (TRA-1-60)
  • flow cytometry; human; 1:100
In order to study two pluripotent stem cell populations in regards to a neural precurson cell population, Santa Cruz Biotechnology PODXL antibody (Santa Cruz, sc-21705) was used in flow cytometry on human samples at 1:100. Stem Cell Res (2014) ncbi
Abcam
mouse monoclonal (TRA-1-60)
  • western blot; human; 1:200; loading ...
Abcam PODXL antibody (Abcam, ab16288) was used in western blot on human samples at 1:200. elife (2021) ncbi
mouse monoclonal (TRA-1-60)
  • immunohistochemistry; human; 1:266; loading ...; fig s2-1c
Abcam PODXL antibody (Abcam, ab16288) was used in immunohistochemistry on human samples at 1:266 (fig s2-1c). elife (2020) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; African green monkey; 1:200; loading ...; fig 5b
  • immunocytochemistry; rhesus macaque; 1:200; loading ...; fig 6a
Abcam PODXL antibody (Abcam, ab16288) was used in immunocytochemistry on African green monkey samples at 1:200 (fig 5b) and in immunocytochemistry on rhesus macaque samples at 1:200 (fig 6a). Cells (2020) ncbi
mouse monoclonal (TRA-1-81)
  • immunocytochemistry; human; 1:200; loading ...; fig 2a
Abcam PODXL antibody (Abcam, ab16289) was used in immunocytochemistry on human samples at 1:200 (fig 2a). Int J Mol Sci (2020) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; 1:200; loading ...; fig 2a
Abcam PODXL antibody (Abcam, ab16288) was used in immunocytochemistry on human samples at 1:200 (fig 2a). Int J Mol Sci (2020) ncbi
mouse monoclonal (TRA-1-81)
  • immunocytochemistry; human; 1:500; loading ...; fig s5d
Abcam PODXL antibody (AbCam, ab16289) was used in immunocytochemistry on human samples at 1:500 (fig s5d). Cell Death Dis (2020) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; loading ...; fig s3a
Abcam PODXL antibody (Abcam, ab16288) was used in immunocytochemistry on human samples (fig s3a). Stem Cell Reports (2020) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; 1:100; loading ...; fig 3a
Abcam PODXL antibody (Abcam, 16288) was used in immunocytochemistry on human samples at 1:100 (fig 3a). Methods Mol Biol (2018) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; loading ...; fig 5d
Abcam PODXL antibody (Abcam, ab16288) was used in immunocytochemistry on human samples (fig 5d). Stem Cell Res (2017) ncbi
mouse monoclonal (TRA-1-60)
  • immunocytochemistry; human; loading ...; fig 2a
Abcam PODXL antibody (Abcam, ab16288) was used in immunocytochemistry on human samples (fig 2a). Front Cell Dev Biol (2015) ncbi
BioLegend
mouse monoclonal (TRA-1-60-R)
  • flow cytometry; human; 1:25; loading ...; fig s6a
BioLegend PODXL antibody (BioLegend, 330610) was used in flow cytometry on human samples at 1:25 (fig s6a). Sci Adv (2020) ncbi
mouse monoclonal (TRA-1-81)
  • flow cytometry; human; loading ...; fig 1e
BioLegend PODXL antibody (BioLegend, Tra-1-81) was used in flow cytometry on human samples (fig 1e). JCI Insight (2019) ncbi
mouse monoclonal (TRA-1-60-R)
  • flow cytometry; human; loading ...; fig 1e
BioLegend PODXL antibody (BioLegend, Tra-1-80-R) was used in flow cytometry on human samples (fig 1e). JCI Insight (2019) ncbi
mouse monoclonal (TRA-1-60-R)
  • flow cytometry; human; fig s1d
BioLegend PODXL antibody (BioLegend, 330606) was used in flow cytometry on human samples (fig s1d). Cell Rep (2019) ncbi
mouse monoclonal (TRA-1-60-R)
  • flow cytometry; human; loading ...; fig 3c
BioLegend PODXL antibody (BioLegend, 330614) was used in flow cytometry on human samples (fig 3c). Stem Cells Transl Med (2019) ncbi
mouse monoclonal (TRA-1-60-R)
  • flow cytometry; human; loading ...; fig 3a
BioLegend PODXL antibody (Biolegend, TRA-1-60-R) was used in flow cytometry on human samples (fig 3a). Sci Rep (2018) ncbi
mouse monoclonal (TRA-1-81)
  • immunocytochemistry; human; 1:125; loading ...; fig s10a
BioLegend PODXL antibody (Biolegend, 330702) was used in immunocytochemistry on human samples at 1:125 (fig s10a). Nat Commun (2017) ncbi
mouse monoclonal (TRA-1-81)
  • immunocytochemistry; human; 1:200; loading ...; tbl s4
BioLegend PODXL antibody (Biolegend, 330702) was used in immunocytochemistry on human samples at 1:200 (tbl s4). Stem Cell Res (2016) ncbi
mouse monoclonal (TRA-1-60-R)
  • immunocytochemistry; human; 1:200; loading ...; tbl s4
BioLegend PODXL antibody (Biolegend, 330602) was used in immunocytochemistry on human samples at 1:200 (tbl s4). Stem Cell Res (2016) ncbi
mouse monoclonal (TRA-1-81)
  • immunocytochemistry; human; 1:200; loading ...; tbl 2
BioLegend PODXL antibody (Biolegend, 330702) was used in immunocytochemistry on human samples at 1:200 (tbl 2). Stem Cell Res (2016) ncbi
mouse monoclonal (TRA-1-60-R)
  • immunocytochemistry; human; 1:200; loading ...; tbl 2
BioLegend PODXL antibody (Biolegend, 330602) was used in immunocytochemistry on human samples at 1:200 (tbl 2). Stem Cell Res (2016) ncbi
mouse monoclonal (TRA-1-81)
  • immunocytochemistry; human; 1:200; fig 1d
BioLegend PODXL antibody (BioLegend, 330,702) was used in immunocytochemistry on human samples at 1:200 (fig 1d). Stem Cell Res (2016) ncbi
mouse monoclonal (TRA-1-60-R)
  • immunocytochemistry; human; 1:200; fig 1d
BioLegend PODXL antibody (BioLegend, 330,602) was used in immunocytochemistry on human samples at 1:200 (fig 1d). Stem Cell Res (2016) ncbi
mouse monoclonal (TRA-1-60-R)
  • immunocytochemistry; human; tbl 2
BioLegend PODXL antibody (Biolegend, 330605) was used in immunocytochemistry on human samples (tbl 2). Exp Cell Res (2015) ncbi
mouse monoclonal (TRA-1-60-R)
BioLegend PODXL antibody (Biolegend, 330605) was used . PLoS ONE (2014) ncbi
mouse monoclonal (TRA-1-60-R)
  • flow cytometry; human; 1:50
In order to report the generation of human fibroblast-derived hepatocytes that can be used to repopulate mouse livers, BioLegend PODXL antibody (Biolegend, 330609) was used in flow cytometry on human samples at 1:50. Nature (2014) ncbi
Miltenyi Biotec
human monoclonal (REA157)
  • flow cytometry; human; loading ...; fig 2b
  • immunohistochemistry; human; loading ...; fig 2a
Miltenyi Biotec PODXL antibody (Miltenyi Biotec, REA157) was used in flow cytometry on human samples (fig 2b) and in immunohistochemistry on human samples (fig 2a). Stem Cell Res Ther (2018) ncbi
human monoclonal (REA157)
  • flow cytometry; human; loading ...; fig 1c
Miltenyi Biotec PODXL antibody (Miltenyi, REA157) was used in flow cytometry on human samples (fig 1c). Stem Cells Dev (2018) ncbi
human monoclonal (REA157)
  • immunocytochemistry; human; loading ...; fig 7b
In order to identify SAMD9 mutations in children with MIRAGE syndrome, Miltenyi Biotec PODXL antibody (Miltenyi Biotec, REA157) was used in immunocytochemistry on human samples (fig 7b). J Clin Invest (2017) ncbi
R&D Systems
domestic goat polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig s7a
R&D Systems PODXL antibody (R&D Systems, AF1556) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig s7a). Nat Commun (2021) ncbi
domestic goat polyclonal
  • immunohistochemistry; mouse; 1:300; loading ...; fig s5a
R&D Systems PODXL antibody (R&D Systems, AF1556) was used in immunohistochemistry on mouse samples at 1:300 (fig s5a). Development (2021) ncbi
domestic goat polyclonal
  • immunocytochemistry; human; 1:1000; loading ...; fig 2a
R&D Systems PODXL antibody (R&D, AF 1658) was used in immunocytochemistry on human samples at 1:1000 (fig 2a). Sci Rep (2021) ncbi
Novus Biologicals
mouse monoclonal (3D3)
  • western blot; human; loading ...; fig s2
In order to discuss methods to increase the urinary extracellular vesicle yield, Novus Biologicals PODXL antibody (Novus Biologicals, 3D3) was used in western blot on human samples (fig s2). Eur J Pharm Sci (2017) ncbi
mouse monoclonal (3D3)
  • western blot; human; loading ...; fig s4
In order to characterize podocalyxin conditional knockout mice and study endothelial cells, Novus Biologicals PODXL antibody (Novusbio, NBP2-25219) was used in western blot on human samples (fig s4). Eur J Cell Biol (2016) ncbi
Abnova
mouse monoclonal (4F10)
  • western blot; human; 1:5000
Abnova PODXL antibody (Abnova, 4F10) was used in western blot on human samples at 1:5000. J Proteome Res (2014) ncbi
Cell Signaling Technology
mouse monoclonal (S)
  • immunocytochemistry; human; 1:500; loading ...; fig s1
In order to evaluate stem cell-based disease model for Wolman disease, Cell Signaling Technology PODXL antibody (Cell Signaling, 4746) was used in immunocytochemistry on human samples at 1:500 (fig s1). Orphanet J Rare Dis (2017) ncbi
mouse monoclonal (S)
  • immunocytochemistry; human; 1:400; fig s1
Cell Signaling Technology PODXL antibody (Cell Signaling, TRA-1-60) was used in immunocytochemistry on human samples at 1:400 (fig s1). Nat Med (2016) ncbi
mouse monoclonal (S)
  • immunocytochemistry; human; 1:800; tbl s1
In order to discuss how to use induced-pluripotent stem cells to generate neuron-like cells, Cell Signaling Technology PODXL antibody (Cell Signaling, 4746) was used in immunocytochemistry on human samples at 1:800 (tbl s1). J Chin Med Assoc (2015) ncbi
mouse monoclonal (S)
  • immunocytochemistry; pigs ; fig 1
Cell Signaling Technology PODXL antibody (Cell Signaling, 4746P) was used in immunocytochemistry on pigs samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (S)
  • immunocytochemistry; human; 1:200
Cell Signaling Technology PODXL antibody (Cell Signaling, 4746) was used in immunocytochemistry on human samples at 1:200. PLoS ONE (2014) ncbi
mouse monoclonal (S)
  • immunocytochemistry; human; 1:800
In order to study age-related macular degeneration pathogenesis using stem cells differentiation into retinal pigment epithelial cells using T cells, Cell Signaling Technology PODXL antibody (Cell signaling, 4746) was used in immunocytochemistry on human samples at 1:800. Front Aging Neurosci (2014) ncbi
Articles Reviewed
  1. Rodriguez Polo I, Mißbach S, Petkov S, Mattern F, Maierhofer A, Grządzielewska I, et al. A piggyBac-based platform for genome editing and clonal rhesus macaque iPSC line derivation. Sci Rep. 2021;11:15439 pubmed publisher
  2. Liang F, Wang B, Geng J, You G, Fa J, Zhang M, et al. SORBS2 is a genetic factor contributing to cardiac malformation of 4q deletion syndrome patients. elife. 2021;10: pubmed publisher
  3. Nam J, Kim A, Choi S, Kim J, Choi K, Cho S, et al. An antibody against L1 cell adhesion molecule inhibits cardiotoxicity by regulating persistent DNA damage. Nat Commun. 2021;12:3279 pubmed publisher
  4. Li H, Kurtzeborn K, Kupari J, Gui Y, Siefker E, Lu B, et al. Postnatal prolongation of mammalian nephrogenesis by excess fetal GDNF. Development. 2021;148: pubmed publisher
  5. Yamamura Y, Furuichi K, Murakawa Y, Hirabayashi S, Yoshihara M, Sako K, et al. Identification of candidate PAX2-regulated genes implicated in human kidney development. Sci Rep. 2021;11:9123 pubmed publisher
  6. Qanash H, Li Y, Smith R, Linask K, Young Baird S, Hakami W, et al. Eltrombopag Improves Erythroid Differentiation in a Human Induced Pluripotent Stem Cell Model of Diamond Blackfan Anemia. Cells. 2021;10: pubmed publisher
  7. Roth J, Muench K, Asokan A, Mallett V, Gai H, Verma Y, et al. 16p11.2 microdeletion imparts transcriptional alterations in human iPSC-derived models of early neural development. elife. 2020;9: pubmed publisher
  8. Kim K, Wu Y, Yoon J, Adachi K, Wu G, Velychko S, et al. Reprogramming competence of OCT factors is determined by transactivation domains. Sci Adv. 2020;6: pubmed publisher
  9. Stauske M, Rodriguez Polo I, Haas W, Knorr D, Borchert T, Streckfuss Bömeke K, et al. Non-Human Primate iPSC Generation, Cultivation, and Cardiac Differentiation under Chemically Defined Conditions. Cells. 2020;9: pubmed publisher
  10. Schrank S, McDaid J, Briggs C, Mustaly Kalimi S, Brinks D, Houcek A, et al. Human-Induced Neurons from Presenilin 1 Mutant Patients Model Aspects of Alzheimer's Disease Pathology. Int J Mol Sci. 2020;21: pubmed publisher
  11. Marin Navarro A, Pronk R, van der Geest A, Oliynyk G, Nordgren A, Arsenian Henriksson M, et al. p53 controls genomic stability and temporal differentiation of human neural stem cells and affects neural organization in human brain organoids. Cell Death Dis. 2020;11:52 pubmed publisher
  12. Ahfeldt T, Ordureau A, Bell C, Sarrafha L, Sun C, Piccinotti S, et al. Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic Neurons. Stem Cell Reports. 2020;14:75-90 pubmed publisher
  13. Battaglia R, Beltran A, Delic S, Dumitru R, Robinson J, Kabiraj P, et al. Site-specific phosphorylation and caspase cleavage of GFAP are new markers of Alexander disease severity. elife. 2019;8: pubmed publisher
  14. Shin W, Seo J, Choi H, Hong Y, Lee W, Chae J, et al. Derivation of primitive neural stem cells from human-induced pluripotent stem cells. J Comp Neurol. 2019;527:3023-3033 pubmed publisher
  15. Ruiz Gutierrez M, Bölükbaşı Ö, Alexe G, Kotini A, Ballotti K, Joyce C, et al. Therapeutic discovery for marrow failure with MDS predisposition using pluripotent stem cells. JCI Insight. 2019;5: pubmed publisher
  16. Mair B, Tomic J, Masud S, Tonge P, Weiss A, Usaj M, et al. Essential Gene Profiles for Human Pluripotent Stem Cells Identify Uncharacterized Genes and Substrate Dependencies. Cell Rep. 2019;27:599-615.e12 pubmed publisher
  17. Kaindl J, Meiser I, Majer J, Sommer A, Krach F, Katsen Globa A, et al. Zooming in on Cryopreservation of hiPSCs and Neural Derivatives: A Dual-Center Study Using Adherent Vitrification. Stem Cells Transl Med. 2019;8:247-259 pubmed publisher
  18. Hayashi R, Ishikawa Y, Katayama T, Quantock A, Nishida K. CD200 facilitates the isolation of corneal epithelial cells derived from human pluripotent stem cells. Sci Rep. 2018;8:16550 pubmed publisher
  19. Weltner J, Balboa D, Katayama S, Bespalov M, Krjutskov K, Jouhilahti E, et al. Human pluripotent reprogramming with CRISPR activators. Nat Commun. 2018;9:2643 pubmed publisher
  20. Rahman M, Spitzhorn L, Wruck W, Hagenbeck C, Balan P, Graffmann N, et al. The presence of human mesenchymal stem cells of renal origin in amniotic fluid increases with gestational time. Stem Cell Res Ther. 2018;9:113 pubmed publisher
  21. Jansch C, Günther K, Waider J, Ziegler G, Forero A, Kollert S, et al. Generation of a human induced pluripotent stem cell (iPSC) line from a 51-year-old female with attention-deficit/hyperactivity disorder (ADHD) carrying a duplication of SLC2A3. Stem Cell Res. 2018;28:136-140 pubmed publisher
  22. He J, Weng Z, Wu S, Boheler K. Generation of Induced Pluripotent Stem Cells from Patients with COL3A1 Mutations and Differentiation to Smooth Muscle Cells for ECM-Surfaceome Analyses. Methods Mol Biol. 2018;1722:261-302 pubmed publisher
  23. Yuan F, Guo D, Liu Y, Xu Y, Gao G, Wu Y, et al. Generation of an ASS1 heterozygous knockout human embryonic stem cell line, WAe001-A-13, using CRISPR/Cas9. Stem Cell Res. 2018;26:67-71 pubmed publisher
  24. Simara P, Tesarova L, Rehakova D, Farkas S, Salingova B, Kutalkova K, et al. Reprogramming of Adult Peripheral Blood Cells into Human Induced Pluripotent Stem Cells as a Safe and Accessible Source of Endothelial Cells. Stem Cells Dev. 2018;27:10-22 pubmed publisher
  25. Chen X, Janssen J, Liu J, Maggio I, t Jong A, Mikkers H, et al. In trans paired nicking triggers seamless genome editing without double-stranded DNA cutting. Nat Commun. 2017;8:657 pubmed publisher
  26. Aguisanda F, Yeh C, Chen C, Li R, Beers J, Zou J, et al. Neural stem cells for disease modeling of Wolman disease and evaluation of therapeutics. Orphanet J Rare Dis. 2017;12:120 pubmed publisher
  27. Raya Sandino A, Castillo Kauil A, Domínguez Calderón A, Alarcón L, Flores Benitez D, Cuellar Perez F, et al. Zonula occludens-2 regulates Rho proteins activity and the development of epithelial cytoarchitecture and barrier function. Biochim Biophys Acta Mol Cell Res. 2017;1864:1714-1733 pubmed publisher
  28. Buonocore F, Kühnen P, Suntharalingham J, Del Valle I, Digweed M, Stachelscheid H, et al. Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans. J Clin Invest. 2017;127:1700-1713 pubmed publisher
  29. VALLABHAJOSYULA P, Korutla L, Habertheuer A, Yu M, Rostami S, Yuan C, et al. Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest. 2017;127:1375-1391 pubmed publisher
  30. Arioka Y, Ito H, Hirata A, Semi K, Yamada Y, Seishima M. Behavior of leucine-rich repeat-containing G-protein coupled receptor 5-expressing cells in the reprogramming process. Stem Cell Res. 2017;20:1-9 pubmed publisher
  31. Ercan E, Han J, Di Nardo A, Winden K, Han M, Hoyo L, et al. Neuronal CTGF/CCN2 negatively regulates myelination in a mouse model of tuberous sclerosis complex. J Exp Med. 2017;214:681-697 pubmed publisher
  32. Borghesi J, Mario L, Carreira A, Miglino M, Favaron P. Phenotype and multipotency of rabbit (Oryctolagus cuniculus) amniotic stem cells. Stem Cell Res Ther. 2017;8:27 pubmed publisher
  33. Bharathan S, Manian K, Aalam S, Palani D, Deshpande P, Pratheesh M, et al. Systematic evaluation of markers used for the identification of human induced pluripotent stem cells. Biol Open. 2017;6:100-108 pubmed publisher
  34. Fall B, Scott C, Mauer M, Shankland S, Pippin J, Jefferson J, et al. Urinary Podocyte Loss Is Increased in Patients with Fabry Disease and Correlates with Clinical Severity of Fabry Nephropathy. PLoS ONE. 2016;11:e0168346 pubmed publisher
  35. Herring A, Messana A, Bara A, Hazelbaker D, Eggan K, Barrett L. Generation of a TLE1 homozygous knockout human embryonic stem cell line using CRISPR-Cas9. Stem Cell Res. 2016;17:430-432 pubmed publisher
  36. Puhka M, Nordberg M, Valkonen S, Rannikko A, Kallioniemi O, Siljander P, et al. KeepEX, a simple dilution protocol for improving extracellular vesicle yields from urine. Eur J Pharm Sci. 2017;98:30-39 pubmed publisher
  37. Yoffe Y, David M, Kalaora R, Povodovski L, Friedlander G, Feldmesser E, et al. Cap-independent translation by DAP5 controls cell fate decisions in human embryonic stem cells. Genes Dev. 2016;30:1991-2004 pubmed publisher
  38. Hansen S, Stummann T, Borland H, Hasholt L, Tumer Z, Nielsen J, et al. Induced pluripotent stem cell - derived neurons for the study of spinocerebellar ataxia type 3. Stem Cell Res. 2016;17:306-317 pubmed publisher
  39. Quintanilla R, Asprer J, Sylakowski K, Lakshmipathy U. Kinetic Measurement and Real Time Visualization of Somatic Reprogramming. J Vis Exp. 2016;: pubmed publisher
  40. Nakao H, Matsumoto S, Nagai Y, Kojima A, Toyoda H, Hashii N, et al. Characterization of glycoproteins expressing the blood group H type 1 epitope on human induced pluripotent stem (hiPS) cells. Glycoconj J. 2017;34:779-787 pubmed publisher
  41. Achuta V, Grym H, Putkonen N, Louhivuori V, Kärkkäinen V, Koistinaho J, et al. Metabotropic glutamate receptor 5 responses dictate differentiation of neural progenitors to NMDA-responsive cells in fragile X syndrome. Dev Neurobiol. 2017;77:438-453 pubmed publisher
  42. Hansen S, Borland H, Hasholt L, Tumer Z, Nielsen J, Rasmussen M, et al. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.B11. Stem Cell Res. 2016;16:589-92 pubmed publisher
  43. Hansen S, Borland H, Hasholt L, Tumer Z, Nielsen J, Rasmussen M, et al. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11. Stem Cell Res. 2016;16:553-6 pubmed publisher
  44. Woolnough J, Atwood B, Liu Z, Zhao R, Giles K. The Regulation of rRNA Gene Transcription during Directed Differentiation of Human Embryonic Stem Cells. PLoS ONE. 2016;11:e0157276 pubmed publisher
  45. Horrillo A, Porras G, Ayuso M, González Manchón C. Loss of endothelial barrier integrity in mice with conditional ablation of podocalyxin (Podxl) in endothelial cells. Eur J Cell Biol. 2016;95:265-76 pubmed publisher
  46. Momcilovic O, Sivapatham R, Oron T, Meyer M, Mooney S, Rao M, et al. Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations. PLoS ONE. 2016;11:e0154890 pubmed publisher
  47. Reboun M, Rybová J, Dobrovolny R, Vcelak J, Veselková T, Storkanova G, et al. X-Chromosome Inactivation Analysis in Different Cell Types and Induced Pluripotent Stem Cells Elucidates the Disease Mechanism in a Rare Case of Mucopolysaccharidosis Type II in a Female. Folia Biol (Praha). 2016;62:82-9 pubmed
  48. Burridge P, Li Y, Matsa E, Wu H, Ong S, Sharma A, et al. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nat Med. 2016;22:547-56 pubmed publisher
  49. Sa Ngiamsuntorn K, Wongkajornsilp A, Phanthong P, Borwornpinyo S, Kitiyanant N, Chantratita W, et al. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host. Virol J. 2016;13:59 pubmed publisher
  50. Francis K, Ton A, Xin Y, O Halloran P, Wassif C, Malik N, et al. Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypes. Nat Med. 2016;22:388-96 pubmed publisher
  51. Kang L, Yao C, Khodadadi Jamayran A, Xu W, Zhang R, Banerjee N, et al. The Universal 3D3 Antibody of Human PODXL Is Pluripotent Cytotoxic, and Identifies a Residual Population After Extended Differentiation of Pluripotent Stem Cells. Stem Cells Dev. 2016;25:556-68 pubmed publisher
  52. Mikhailova A, Ilmarinen T, Ratnayake A, Petrovski G, Uusitalo H, Skottman H, et al. Human pluripotent stem cell-derived limbal epithelial stem cells on bioengineered matrices for corneal reconstruction. Exp Eye Res. 2016;146:26-34 pubmed publisher
  53. Epsztejn Litman S, Cohen Hadad Y, Aharoni S, Altarescu G, Renbaum P, Levy Lahad E, et al. Establishment of Homozygote Mutant Human Embryonic Stem Cells by Parthenogenesis. PLoS ONE. 2015;10:e0138893 pubmed publisher
  54. Alves C, Dariolli R, Jorge F, Monteiro M, Maximino J, Martins R, et al. Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration. Front Cell Neurosci. 2015;9:289 pubmed publisher
  55. Liu J, Brzeszczynska J, Samuel K, Black J, Palakkan A, Anderson R, et al. Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism. Exp Cell Res. 2015;338:203-13 pubmed publisher
  56. Gallego Romero I, Pavlovic B, Hernando Herraez I, Zhou X, WARD M, Banovich N, et al. A panel of induced pluripotent stem cells from chimpanzees: a resource for comparative functional genomics. elife. 2015;4:e07103 pubmed publisher
  57. Matsumoto S, Nakao H, Kawabe K, Nonaka M, Toyoda H, Takishima Y, et al. A Cytotoxic Antibody Recognizing Lacto-N-fucopentaose I (LNFP I) on Human Induced Pluripotent Stem (hiPS) Cells. J Biol Chem. 2015;290:20071-85 pubmed publisher
  58. Trokovic R, Weltner J, Noisa P, Raivio T, Otonkoski T. Combined negative effect of donor age and time in culture on the reprogramming efficiency into induced pluripotent stem cells. Stem Cell Res. 2015;15:254-62 pubmed publisher
  59. Trokovic R, Weltner J, Otonkoski T. Generation of iPSC line HEL47.2 from healthy human adult fibroblasts. Stem Cell Res. 2015;15:263-5 pubmed publisher
  60. Trokovic R, Weltner J, Otonkoski T. Generation of iPSC line HEL24.3 from human neonatal foreskin fibroblasts. Stem Cell Res. 2015;15:266-8 pubmed publisher
  61. Lenzi J, De Santis R, de Turris V, Morlando M, Laneve P, Calvo A, et al. ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons. Dis Model Mech. 2015;8:755-66 pubmed publisher
  62. Tsai P, Chang Y, Lee Y, Ko Y, Yang Y, Lin C, et al. Differentiation of blood T cells: Reprogramming human induced pluripotent stem cells into neuronal cells. J Chin Med Assoc. 2015;78:353-9 pubmed publisher
  63. Huang Z, Huang Y, He H, Ni J. Podocalyxin promotes cisplatin chemoresistance in osteosarcoma cells through phosphatidylinositide 3-kinase signaling. Mol Med Rep. 2015;12:3916-3922 pubmed publisher
  64. Wu J, Okamura D, Li M, Suzuki K, Luo C, Ma L, et al. An alternative pluripotent state confers interspecies chimaeric competency. Nature. 2015;521:316-21 pubmed publisher
  65. Zhou Y, Zhang L, Pan H, Wang B, Yan F, Fang X, et al. Bmi1 essentially mediates podocalyxin-enhanced Cisplatin chemoresistance in oral tongue squamous cell carcinoma. PLoS ONE. 2015;10:e0123208 pubmed publisher
  66. Zhang W, Pei Y, Zhong L, Wen B, Cao S, Han J. Pluripotent and Metabolic Features of Two Types of Porcine iPSCs Derived from Defined Mouse and Human ES Cell Culture Conditions. PLoS ONE. 2015;10:e0124562 pubmed publisher
  67. Moore J, Loeb D, Hong K, Sorensen P, Triche T, Lee D, et al. Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line. Front Cell Dev Biol. 2015;3:15 pubmed publisher
  68. Debowski K, Warthemann R, Lentes J, Salinas Riester G, Dressel R, Langenstroth D, et al. Non-viral generation of marmoset monkey iPS cells by a six-factor-in-one-vector approach. PLoS ONE. 2015;10:e0118424 pubmed publisher
  69. Liu B, Liu Y, Jiang Y. Podocalyxin promotes glioblastoma multiforme cell invasion and proliferation by inhibiting angiotensin-(1-7)/Mas signaling. Oncol Rep. 2015;33:2583-91 pubmed publisher
  70. Wong A, Chin S, Xia S, Garner J, Bear C, Rossant J. Efficient generation of functional CFTR-expressing airway epithelial cells from human pluripotent stem cells. Nat Protoc. 2015;10:363-81 pubmed publisher
  71. Afzal M, Strande J. Generation of induced pluripotent stem cells from muscular dystrophy patients: efficient integration-free reprogramming of urine derived cells. J Vis Exp. 2015;:52032 pubmed publisher
  72. Denton K, Xu C, Li X. Modeling Axonal Phenotypes with Human Pluripotent Stem Cells. Methods Mol Biol. 2016;1353:309-21 pubmed publisher
  73. Sivapatham R, Zeng X. Generation and Characterization of Patient-Specific Induced Pluripotent Stem Cell for Disease Modeling. Methods Mol Biol. 2016;1353:25-44 pubmed publisher
  74. Busskamp V, Lewis N, Guye P, Ng A, Shipman S, Byrne S, et al. Rapid neurogenesis through transcriptional activation in human stem cells. Mol Syst Biol. 2014;10:760 pubmed publisher
  75. Shimamoto A, Kagawa H, Zensho K, Sera Y, Kazuki Y, Osaki M, et al. Reprogramming suppresses premature senescence phenotypes of Werner syndrome cells and maintains chromosomal stability over long-term culture. PLoS ONE. 2014;9:e112900 pubmed publisher
  76. Liu Y, Yang L, Liu B, Jiang Y. Podocalyxin promotes glioblastoma multiforme cell invasion and proliferation via β-catenin signaling. PLoS ONE. 2014;9:e111343 pubmed publisher
  77. Genovese F, Gualandi A, Taddia L, Marverti G, Pirondi S, Marraccini C, et al. Mass spectrometric/bioinformatic identification of a protein subset that characterizes the cellular activity of anticancer peptides. J Proteome Res. 2014;13:5250-61 pubmed publisher
  78. Chou C, Sinden J, Couraud P, Modo M. In vitro modeling of the neurovascular environment by coculturing adult human brain endothelial cells with human neural stem cells. PLoS ONE. 2014;9:e106346 pubmed publisher
  79. Chang Y, Chang W, Hung K, Yang D, Cheng Y, Liao Y, et al. The generation of induced pluripotent stem cells for macular degeneration as a drug screening platform: identification of curcumin as a protective agent for retinal pigment epithelial cells against oxidative stress. Front Aging Neurosci. 2014;6:191 pubmed publisher
  80. Jiang J, Liu Y, Fang W, Liu F. Sperm?associated antigen 9 promotes astrocytoma cell invasion through the upregulation of podocalyxin. Mol Med Rep. 2014;10:417-22 pubmed publisher
  81. Chung K, Kolling F, Gajdosik M, Burger S, Russell A, Nelson C. Single cell analysis reveals the stochastic phase of reprogramming to pluripotency is an ordered probabilistic process. PLoS ONE. 2014;9:e95304 pubmed publisher
  82. Pryzhkova M, Aria I, Cheng Q, Harris G, Zan X, Gharib M, et al. Carbon nanotube-based substrates for modulation of human pluripotent stem cell fate. Biomaterials. 2014;35:5098-109 pubmed publisher
  83. Zhu S, Rezvani M, Harbell J, Mattis A, Wolfe A, Benet L, et al. Mouse liver repopulation with hepatocytes generated from human fibroblasts. Nature. 2014;508:93-7 pubmed publisher
  84. Gkountela S, Li Z, Chin C, Lee S, Clark A. PRMT5 is required for human embryonic stem cell proliferation but not pluripotency. Stem Cell Rev. 2014;10:230-9 pubmed publisher
  85. Mallon B, Hamilton R, Kozhich O, Johnson K, Fann Y, Rao M, et al. Comparison of the molecular profiles of human embryonic and induced pluripotent stem cells of isogenic origin. Stem Cell Res. 2014;12:376-86 pubmed publisher
  86. Okatsu K, Uno M, Koyano F, Go E, Kimura M, Oka T, et al. A dimeric PINK1-containing complex on depolarized mitochondria stimulates Parkin recruitment. J Biol Chem. 2013;288:36372-84 pubmed publisher
  87. Wu H, Yang L, Liao D, Chen Y, Wang W, Fang J. Podocalyxin regulates astrocytoma cell invasion and survival against temozolomide. Exp Ther Med. 2013;5:1025-1029 pubmed
  88. Onder T, Kara N, Cherry A, Sinha A, Zhu N, Bernt K, et al. Chromatin-modifying enzymes as modulators of reprogramming. Nature. 2012;483:598-602 pubmed publisher
  89. Ruff D, Macarthur C, Tran H, Bergseid J, Tian J, Shannon M, et al. Applications of quantitative polymerase chain reaction protein assays during reprogramming. Stem Cells Dev. 2012;21:530-8 pubmed publisher
  90. Wang D, Li Y, Wu C, Liu Y. PINCH1 is transcriptional regulator in podocytes that interacts with WT1 and represses podocalyxin expression. PLoS ONE. 2011;6:e17048 pubmed publisher
  91. Hotta A, Cheung A, Farra N, Vijayaragavan K, Séguin C, Draper J, et al. Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency. Nat Methods. 2009;6:370-6 pubmed publisher